Next Century Growth Investors’s Mirum Pharmaceuticals MIRM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$49.2M Buy
420,213
+34,674
+9% +$3.48M 2.61% 6
2026
Q1
$35.6M Buy
385,539
+17,504
+5% +$1.65M 2.58% 6
2025
Q4
$29.1M Buy
368,035
+7,101
+2% +$510K 2.02% 9
2025
Q3
$26.5M Buy
360,934
+170,609
+90% +$10.8M 1.93% 11
2025
Q2
$9.69M Sell
190,325
-5,016
-3% -$223K 0.75% 48
2025
Q1
$8.8M Buy
195,341
+31,089
+19% +$1.47M 0.78% 47
2024
Q4
$6.79M Sell
164,252
-119
-0.1% -$4.96K 0.51% 75
2024
Q3
$6.41M Buy
+164,371
New +$6.56M 0.52% 64

Other funds holding MIRM

Next Century Growth Investors's MIRM Position: Q2 2026 in Review

Next Century Growth Investors increased its Mirum Pharmaceuticals (MIRM) stake by 9% in Q2 2026, buying an estimated $3.48M and bringing the position to 420,213 shares worth $49.2M. The position accounts for 2.61% of the portfolio, ranked #6.

Next Century Growth Investors first reported a position in MIRM in Q3 2024 and has held it in 8 quarters since. 327 funds tracked by Wall St. Rank hold MIRM as of Q2 2026.

  • Next Century Growth Investors held 420,213 shares of Mirum Pharmaceuticals worth $49.2M as of Q2 2026.
  • Next Century Growth Investors bought 34,674 Mirum Pharmaceuticals shares in Q2 2026, an estimated $3.48M.
  • Mirum Pharmaceuticals made up 2.61% of Next Century Growth Investors's portfolio in Q2 2026, its #6 holding.
  • Next Century Growth Investors first reported a position in Mirum Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
  • 327 funds tracked by Wall St. Rank held Mirum Pharmaceuticals as of Q2 2026.

Based on Next Century Growth Investors's 13F filing for Q2 2026, filed 14 Aug 2026.